05 May 2006
Update on MED2002
Futura Medical plc (AIM: FUM), the pharmaceutical drug and medical device group that develops innovative products for sexual health, announces that it has been advised by the major global pharmaceutical group (MGPG) that the formal approval process is in its final stage.
James Barder, Futura's Chief Executive, said: "We are informed by MGPG that MED2002 remains a high priority for them."